relative to increasing transparency in the 340B Drug Pricing Program.

{"id": "ocd-bill/8cb1ec0e-7070-4925-bfef-1c4bff9229be", "session": "2026", "jurisdiction": {"id": "ocd-jurisdiction/country:us/state:nh/government", "name": "New Hampshire", "classification": "state"}, "from_organization": {"id": "ocd-organization/c95932a0-2ac1-4f14-a0c4-ade8568daac6", "name": "Senate", "classification": "upper"}, "identifier": "SB 477", "title": "relative to increasing transparency in the 340B Drug Pricing Program.", "classification": ["bill"], "subject": [], "extras": {"LSR": "2036", "_code": ""}, "created_at": "2025-12-09T21:08:18.765770+00:00", "updated_at": "2026-06-02T17:37:07.761898+00:00", "openstates_url": "https://openstates.org/nh/bills/2026/SB477/", "first_action_date": "2025-11-21", "latest_action_date": "2026-03-05", "latest_action_description": "Refer to Interim Study, MA, VV; 03/05/2026;  SJ 5", "latest_passage_date": ""}